Using female mice, researchers find that a frequently used breast cancer treatment impairs molecular and behavioral measures of the primary biological clock found in the brain.

Clinical trials show promising results in treating pancreatic and colorectal cancers

New treatment strategies improve outcomes for patients with kidney and testicular cancers

Novel research techniques enable advances in gene-drug interactions, breast cancer progression, and identifying pre-cancerous lesions

Biomarkers help predict risk for oral cancer metastasis

Researchers at University of Tsukuba have identified the molecular mechanism through which the tumor glycoprotein Glycoprotein non-metastatic melanoma protein B (GPNMB) promotes the differentiation of immunosuppressive tumor-associated macrophages (TAMs). This process facilitates the epithelial-mesenchymal transition (EMT) and metastasis in triple-negative breast cancer (TNBC), one of the most aggressive subtypes of breast cancer.

A study published in the Journal of Geriatric Oncology highlights a significant gap in the care of older adults with breast cancer: while many face age-related risks that could complicate treatment, a majority decline supportive services even when those risks are identified.

The American Society for Radiation Oncology (ASTRO) announced today the press program for its 2025 Annual Meeting this month in San Francisco. Researchers will discuss their findings in news briefings on Sept. 29 and 30, and complimentary meeting registration is available for credentialed press. The field's most influential scientific forum, ASTRO's Annual Meeting will feature pivotal studies in radiation medicine for patients with cancer and other diseases.